Dutch specialty pharma company Pharming Group (Euronext: PHARM) has been named in an injunction secured in the USA by CSL Behring over the alleged stealing of proprietary information.
The blood products and vaccines specialist, which is part of Australia’s CSL Limited (ASX: CSL), is seeking to prevent the possible transmission of documents and data to Pharming which – the allegations state – were removed from its systems by Joseph Chiao.
Until last month, Dr Chiao was the therapeutic head of hereditary angioedema (HAE) for CSL Behring, but he resigned and became a medical director at Pharming, another drugmaker which is active in the HAE space.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze